DGAP-News 428 0 Kommentare Evonik Industries AG: Evonik acquires specialist in alternative preservation systems for cosmetic products from Hamburg, Germany - Seite 3

About Evonik Nutrition & Care

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling essential human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,500 employees, and generated sales of around EUR4.3 billion in 2016.

Disclaimer

In so far as forecasts or expectations are expressed in this Investor Relations News or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Short

19,39€

Basispreis

0,13

Ask

× 14,03

Hebel

Zum Produkt

Long

16,87€

Basispreis

1,52

Ask

× 12,00

Hebel

Zum Produkt

Präsentiert von

Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

Contact:
Tim Lange

Head of Investor Relations

Phone +49 201 177-3150

tim.lange@evonik.com

Evonik Industries AG

Rellinghauser Straße 1-11

45128 Essen

Germany

Phone +49 201 177-01

Fax +49 201 177-3475

www.evonik.com

Supervisory Board

Dr. Werner Müller, Chairman
Executive Board

Dr. Klaus Engel, Chairman

Christian Kullmann, Deputy Chairman

Dr. Ralph Sven Kaufmann

Thomas Wessel

Ute Wolf

Registered Office is Essen

Register Court Essen Local Court

Commercial Registry B 19474

13.03.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Evonik Industries AG
	Rellinghauser Straße 1-11
	45128 Essen
	Germany
Phone:	+49 (0) 201 177-01
Fax:	+49 (0) 201 177-3475
E-mail:	investor-relations@evonik.com
Internet:	www.evonik.com
ISIN:	DE000EVNK013, XS0911405784
WKN:	EVNK01, A1TM7T
Indices:	MDAX
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Luxemburg